Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Ministry of Education, Science and Sport of the Republic of Slovenia (P3-0289)
Krka d.d. Novo Mesto (Trial KCT 04/2015-DORETAonko/si)
- License Information
-
More Information
Article History
Received: 14 February 2020
Accepted: 26 May 2020
First Online: 18 June 2020
Compliance with ethical standards
:
: N. Besic and B. Strazisar have received a research Grant Trial KCT 04/2015-DORETAonko/si from the pharmaceutical company Krka d.d. Novo mesto. J. Smrekar has received a honorarium for the statistical analysis of our study from the pharmaceutical company Krka d.d. Novo mesto.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study Trial KCT 04/2015-DORETAonko/si, EudraCT Number: 2015-000992-28 met the guidelines of their responsible governmental agency and was reviewed and approved by The National Medical Ethics Committee of the Republic of Slovenia (Approval number 32/03/15). Our study was approved by the Institutional Review Board of the Institute of Oncology Ljubljana.
: Informed consent was obtained from all individual participants included in the study.
